Shelter Pharma Ltd
Wed 2/09/2026,16:1:0 | BSE : SHELTER
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 32.00
Previous Close
₹ 33.00
Volume
12000
Mkt Cap ( ₹ Cr)
₹ 53.88
High
₹ 32.00
Low
₹ 32.00
52 Week High
₹ 46.98
52 Week Low
₹ 23.00
Book Value Per Share
₹ 43.29
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Shelter Pharma Ltd
Your Vote -
Buy
40.00%
Hold
20.00%
Sell
40.00%
40.00%
5 users have voted
Option Chain
Analyzes market sentiment, predicts Shelter Pharma Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Shelter Pharma - Intimation Of The Cut-Off Date For The AGM Of The Company \Shelter Pharma Limited\
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Change in Management
-
Shelter Pharma - Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On The Tuesday, 01ST September, 2026
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015 Completion And Commencement Of Dispatch Of Ex
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015 Completion And Commencement Of Dispatch Of Ex
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - New Product Launch.
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015\r\nCompletion And Commencement Of Dispatch Of
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-\r\nCompletion And Commencement Of Dispatch Of
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Shelter Pharma - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On 31St July, 2026
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-\r\nCompletion And Successful Dispatch Of Expo
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Shelter Pharma - Corrigendum To Intimation Of H2 FY2026 Investor Conference Call Withdrawal Of Scheduled Meeting
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-\r\nCompletion And Commencement Of Dispatch Of
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015- Receipt Of Good Manufacturing Practices Cert
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Receipt Of Renewal Manufacturing Licence
Key fundamentals
Evaluate the intrinsic value of Shelter Pharma Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 77.433 | 43.7647 | 36.3931 | 16.2947 | 8.9366 |
| Liabilities | 77.433 | 43.7647 | 36.3931 | 16.2947 | 8.9366 |
| Equity | 16.6118 | 11.5598 | 11.5598 | 7.7438 | 0.4839 |
| Gross Profit | 12.726 | 10.0677 | 8.5714 | 8.0574 | 2.9223 |
| Net Profit | 9.0272 | 7.2374 | 6.2002 | 5.7833 | 1.8569 |
| Cash From Operating Activities | -12.4801 | 5.4822 | -1.8502 | 0.0033 | 0 |
| NPM(%) | 12.34 | 14.28 | 15.49 | 15.99 | 6.17 |
| Revenue | 73.1336 | 50.6602 | 40.0229 | 36.1527 | 30.0554 |
| Expenses | 60.4076 | 40.5925 | 31.4515 | 28.0953 | 27.1331 |
| ROE(%) | 12.38 | 9.92 | 8.5 | 7.93 | 2.54 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Shelter Pharma Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 874.00 | 0.44 | 22.05 | 18.83 | -26.19 | 0.57 |
| Lotus Eye Hospital and Institute Ltd | 109.05 | 0.05 | 1542.57 | 68.63 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 15.55 | -0.26 | 0.00 | 142.49 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 572.25 | 1.05 | 0.00 | 73.53 | -363.14 | 0.00 |
Company Info
The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.
The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.
Read More
Parent Organisation
Shelter Pharma Ltd.
Founded
12/10/2007
Managing Director
Mr.Mustaqim Nisarahmed Sabugar
NSE Symbol
FAQ
The current price of Shelter Pharma Ltd is
The 52-week high for Shelter Pharma Ltd is
The market capitalization of Shelter Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Shelter Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Shelter Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shelter Pharma Ltd shares.
The CEO of Shelter Pharma Ltd is Mr.Mustaqim Nisarahmed Sabugar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.